NYSE$SLQT
Selectquote Inc · Q2 2025 earnings
Q2 2025 earnings · · Investor relations
Briefing
SelectQuote achieved impressive results, driven by strong policy volume and growth in the Healthcare Services segment.
SelectQuote, Inc. reported consolidated revenue for the second quarter of fiscal year 2025 of $481.1 million, compared to $405.4 million for the second quarter of fiscal year 2024. Consolidated net income for the second quarter of fiscal year 2025 was $53.2 million, compared to $19.4 million for the second quarter of fiscal year 2024. Consolidated Adjusted EBITDA was $87.5 million compared to $67.4 million for the second quarter of fiscal year 2024.
- SelectQuote delivered impressive results during the fiscal second quarter.
- Strong policy volume and Senior Adjusted EBITDA margin of 39%, up approximately 750 basis points year-over-year.
- Healthcare Services segment delivered another quarter of strong results, led by SelectRx, with over 96,000 members, representing growth of 54% compared to a year ago.
- Improved capital structure with a $350 million strategic investment led by Bain Capital and Morgan Stanley Private Credit.
Headline financials
Revenue & EPS history
SelectQuote · Revenue · Quarterly
$481M
Revenue by segment
SelectQuote · $128M total across 2 segments · Q1 2024
- Senior$89.9M+16.0%70.4%
- Life$37.8M+2.7%29.6%
Forward guidance
Fiscal Year 2025 Guidance Ranges:
Tailwinds
- Revenue expected in a range of $1.500 billion to $1.575 billion
- Adjusted EBITDA expected in a range of $115 million to $140 million
Headwinds
- Net income (loss) expected in a range of $(24) million to $11 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2025
-2.4%
Avg return
Earnings day
+1.1%
Avg return
5 days after
+2.2%
Avg return
30 days after
57%
17 / 30 earnings
Positive
+75.5%
Q2 2023
Best reaction
-49.0%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -8.9% | +39.9% | +24.3% | |
| Q2 2026 | -29.0% | -37.4% | -47.9% | |
| Q1 2026 | +0.0% | -16.8% | -29.3% | |
| Q3 2025 | -12.1% | -14.2% | -15.4% | |
| Q2 2025 | +30.8% | +37.0% | -17.4% | |
| Q1 2025 | +6.9% | +16.7% | +46.1% | |
| Q4 2024 | -49.0% | -44.6% | -37.6% | |
| Q3 2024 | +4.8% | +12.4% | +13.2% | |
| Q2 2024 | +6.3% | +40.5% | +64.0% | |
| Q1 2024 | -4.3% | -5.8% | -3.6% | |
| Q4 2023 | -16.2% | -16.9% | -8.8% | |
| Q3 2023 | +11.1% | -16.7% | +16.7% | |
| Q2 2023 | +75.5% | +128.8% | +181.1% | |
| Q1 2023 | +9.5% | +9.2% | +17.7% | |
| Q4 2022 | -30.4% | -47.5% | -54.9% | |
| Q3 2022 | +7.5% | +0.4% | +20.4% | |
| Q2 2022 | -48.0% | -55.4% | -60.1% | |
| Q1 2022 | -22.3% | -17.8% | -36.3% | |
| Q4 2021 | -44.6% | -37.6% | -7.2% | |
| Q3 2020 | -21.5% | -22.2% | -23.4% | |
| Q3 2021 | -21.9% | -23.2% | -26.6% | |
| Q2 2020 | +7.7% | +9.2% | +7.4% | |
| Q2 2021 | +7.7% | +9.2% | +7.4% | |
| Q1 2020 | +2.7% | +7.7% | +20.3% | |
| Q1 2021 | +7.6% | +10.5% | +23.0% | |
| Q4 2018 | +10.9% | +12.0% | -2.1% | |
| Q4 2019 | +10.9% | +12.0% | -2.1% | |
| Q3 2019 | +10.9% | +12.0% | -2.1% | |
| Q2 2019 | +10.9% | +12.0% | -2.1% | |
| Q4 2020 | +14.2% | +20.1% | +0.3% | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro